Table of Contents 2
List of Tables 4
List of Figures 4
Akshaya Bio Inc. Spshot 5
Akshaya Bio Inc. Overview 5
Key Facts 5
Akshaya Bio Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Akshaya Bio Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combition Treatment Modalities 10
Akshaya Bio Inc. - Pipeline Products Glance 11
Akshaya Bio Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combition Treatment Modalities 11
Discovery Products/Combition Treatment Modalities 12
Akshaya Bio Inc. - Drug Profiles 13
hepatitis C vaccine - Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
HIV vaccine - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
influenza [strains A/H5N1 + A/H1N1] vaccine - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
malaria vaccine - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
NU-500 - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Vaccine to Target CA9 for Cancer - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Vaccine to Target CEA for Oncology - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Vaccine to Target HER 2/neu for Cancer - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Vaccine to Target MUC1 for Oncology - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Vaccine to Target PAP for Prostate Cancer - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Westrern Equine Encephalitis Virus Vaccine - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Akshaya Bio Inc. - Pipeline Alysis 24
Akshaya Bio Inc. - Pipeline Products by Target 24
Akshaya Bio Inc. - Pipeline Products by Molecule Type 26
Akshaya Bio Inc. - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29